SUSQUEHANNA INTERNATIONAL GROUP, LLP - MERSANA THERAPEUTICS INC ownership

MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 129 filers reported holding MERSANA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 297.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of MERSANA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$399,227
-89.7%
314,352
-73.4%
0.00%
-100.0%
Q2 2023$3,894,429
+108.1%
1,183,717
+160.0%
0.00%
Q1 2023$1,871,225
+699.3%
455,286
+1039.6%
0.00%
Q4 2022$234,119
-66.2%
39,952
-61.0%
0.00%
Q3 2022$692,000
+686.4%
102,415
+436.4%
0.00%
Q2 2022$88,000
-87.3%
19,093
-89.0%
0.00%
Q1 2022$693,000
-54.3%
173,786
-28.8%
0.00%
Q4 2021$1,518,000
+36.8%
243,914
+107.2%
0.00%
Q3 2021$1,110,000
-60.3%
117,741
-42.8%
0.00%
Q2 2021$2,798,000
-57.5%
206,002
-49.3%
0.00%
Q1 2021$6,576,000
+167.1%
406,379
+339.3%
0.00%
Q4 2020$2,462,000
-42.6%
92,514
-59.8%
0.00%
Q3 2020$4,289,000
+196.2%
230,353
+272.4%
0.00%
Q2 2020$1,448,000
+788.3%
61,864
+121.2%
0.00%
Q1 2020$163,000
+526.9%
27,970
+70.7%
0.00%
Q3 2019$26,000
-94.3%
16,381
-85.4%
0.00%
Q2 2019$455,000112,0770.00%
Other shareholders
MERSANA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 5,000,000$6,350,0001.92%
VR Adviser, LLC 11,328,000$14,386,5601.51%
Bain Capital Life Sciences Investors, LLC 8,663,673$11,002,8651.23%
Affinity Asset Advisors, LLC 2,850,000$3,619,5001.02%
EcoR1 Capital, LLC 19,364,688$24,593,1540.83%
Altium Capital Management LP 1,059,136$1,345,1030.70%
5AM Venture Management, LLC 1,305,000$1,657,3500.48%
Decheng Capital Management III (Cayman), LLC 904,268$1,148,4200.38%
COMMODORE CAPITAL LP 2,244,378$2,850,3600.33%
Philosophy Capital Management LLC 2,342,634$2,975,1450.32%
View complete list of MERSANA THERAPEUTICS INC shareholders